Rosenblatt analyst Kevin Cassidy reiterates Luminar Technologies (NASDAQ:LAZR) with a Neutral and maintains $8 price target.
Analyst Expectations for Eli Lilly’s Future
Analysts have provided the following ratings for Eli Lilly (NYSE:LLY) within the last quarter: Bullish Somewhat Bullish Indifferent…